Sector
PharmaceuticalsOpen
₹410.6Prev. Close
₹406.6Turnover(Lac.)
₹2,173.01Day's High
₹433Day's Low
₹40852 Week's High
₹052 Week's Low
₹0Book Value
₹0Face Value
₹2Mkt Cap (₹ Cr.)
2,882.23P/E
65.77EPS
6.52Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
---|---|---|---|---|
Equity Capital | 31.56 | 11.33 | 9.27 | 13.84 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 382.78 | 304.54 | 275.94 | 248.65 |
Net Worth | 414.34 | 315.87 | 285.21 | 262.49 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
---|---|---|---|---|
Revenue | 1,078.39 | 934.71 | 782.75 | 735.9 |
yoy growth (%) | 15.37 | 19.41 | 6.36 | 29.76 |
Raw materials | -628.31 | -541.93 | -484.95 | -468.66 |
As % of sales | 58.26 | 57.97 | 61.95 | 63.68 |
Employee costs | -114.11 | -95.26 | -76.74 | -59.52 |
Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
---|---|---|---|---|
Profit before tax | 44.36 | 27.94 | 23.63 | 37.27 |
Depreciation | -36.84 | -38.14 | -31.66 | -24.72 |
Tax paid | -4.47 | 7.27 | 2.64 | 15.78 |
Working capital | 101.47 | 46.43 | 68.92 | 13.89 |
Other operating items |
Y/e 31 Mar | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.37 | 19.41 | 6.36 | 29.76 |
Op profit growth | 26.22 | 42.47 | 21.86 | 32.41 |
EBIT growth | 41.52 | 41.98 | -33.91 | 120.74 |
Net profit growth | 17.38 | 34.04 | -50.47 | -248.8 |
Particulars (Rupees in Crores.) | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|---|
Gross Sales | 1,251.95 | 1,157.65 | 1,029.66 | 1,014.91 | 790.78 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,251.95 | 1,157.65 | 1,029.66 | 1,014.91 | 790.78 |
Other Operating Income | 64.68 | 55.04 | 55.11 | 51.47 | 43.65 |
Other Income | 20.08 | 22.94 | 18.06 | 40.91 | 21.96 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
R Kannan
Managing Director
S Abhaya Kumar
Whole-time Director
S Vimal Kumar
Company Secretary
S Muralikrishna
Director
R Sundara Rajan
Whole-time Director
S Devendra
Director
N Subramanian
Director
Sunny Sharma
Whole-time Director
Arun Chandra Karmakar
Additional Director
Taru Mayur
Batra Centre 3rd & 4th Floor,
28 Sardar Patel Road Guindy,
Tamil Nadu - 600032
Tel: 91-44-43446700
Website: http://www.shasun.com
Email: [email protected]
Kences Tower,
2nd Floor No 1, Ramakrishna Street,
Chennai - 600 017
Tel: 91-044-28140801/803
Website: www.integratedindia.in
Summary
Shasun Pharmaceuticals (Formerly known as Shasun Chemicals & Drugs Limited (SCDL)) was incorporated on 19th April 1976 as a private limited company under the name of Shasun Chemicals (Madras) Private ...
Read More
Reports by Shasun Pharmaceuticals Ltd Merged
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.